
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer
2
Reading the Fine Print: Why Ingredient Awareness Matters After Cancer
3
Stigmas Faced by Patients With Lung Cancer
4
Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer
5




